Jue Pu
Director/Miembro de la Junta en LEPU BIOPHARMA CO., LTD. .
Fortuna: 63 M $ al 30/04/2024
Cargos activos de Jue Pu
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| LEPU BIOPHARMA CO., LTD. | Director/Miembro de la Junta | 22/04/2020 | - |
Inspirna, Inc.
 Inspirna, Inc. Pharmaceuticals: MajorHealth Technology Inspirna, Inc. operates as a clinical stage biopharmaceutical company which develops molecule and antibody cancer therapeutics. It provides drugs for melanoma, colorectal and triple-negative breast cancers. The firm identifies novel cancer targets using a microRNA based target discovery platform that enable the identification and validation of novel post-transcriptionally regulated targets. The company was founded by Masoud Tavazoie, Sohail Tavazoie, Shahram Seyedin-Noor and Saeed Tavazoie in 2010 and is headquartered in New York, NY. | Director/Miembro de la Junta | 01/10/2018 | - |
Historial de carrera de Jue Pu
Antiguos cargos conocidos de Jue Pu.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| CG ONCOLOGY, INC. | Director/Miembro de la Junta | 01/03/2019 | 01/10/2023 |
| CG ONCOLOGY, INC. | Director/Miembro de la Junta | 01/01/2010 | 01/01/2018 |
| Fundador | 01/01/2010 | 01/01/2018 |
Formación de Jue Pu.
| The Wharton School of the University of Pennsylvania | Undergraduate Degree |
| Stanford University | Graduate Degree |
Estadísticas
Internacional
| Estados Unidos | 5 |
| China | 2 |
Operativa
| Director/Board Member | 4 |
| Founder | 1 |
| Undergraduate Degree | 1 |
Sectorial
| Health Technology | 4 |
| Consumer Services | 3 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 2 |
|---|---|
| CG ONCOLOGY, INC. | Health Technology |
| LEPU BIOPHARMA CO., LTD. | Health Technology |
| Empresas privadas | 1 |
|---|---|
Inspirna, Inc.
Inspirna, Inc. Pharmaceuticals: MajorHealth Technology Inspirna, Inc. operates as a clinical stage biopharmaceutical company which develops molecule and antibody cancer therapeutics. It provides drugs for melanoma, colorectal and triple-negative breast cancers. The firm identifies novel cancer targets using a microRNA based target discovery platform that enable the identification and validation of novel post-transcriptionally regulated targets. The company was founded by Masoud Tavazoie, Sohail Tavazoie, Shahram Seyedin-Noor and Saeed Tavazoie in 2010 and is headquartered in New York, NY. | Health Technology |
- Bolsa de valores
- Insiders
- Jue Pu
- Experiencia
